Sutro Biopharma is a biopharmaceutical company that uses its patented OCFS protein synthesis technology to develop next-generation protein therapeutics for the treatment of human disease.
Sutro is applying its technology to the development of...
Founded in 2003
Total money raised: $90.3M
310 Utah Ave
South San Francisco
Sutro Biopharma raised $16.5M in a Series C round from Skyline Ventures, Lilly Ventures, Amgen Ventures, SV Life Sciences, and Alta Partners
Sutro Biopharma raised $36.5M in a Series C round from Skyline Ventures, Lilly Ventures, Amgen Ventures, SV Life Sciences, and Alta Partners
Sutro Biopharma Secures $36.5M in Series C Financing finsmes.com
Sutro Biopharma raised $15M in a Series B round from Alta Partners and SV Life Sciences
Sutro Biopharma raised $21M in a Series B round from SV Life Sciences and Alta Partners
Fundamental Applied Biology, Inc. Completes $21 Million Series B Financing Daniel S. Gold, PhD, Joins as Chief Executive Officer sutrobio.com
Sutro Biopharma raised $305K in unattributed round from SV Life Sciences and International Biotechnology Trust
Sutro Biopharma raised $1M in a Series A round from SV Life Sciences
Sutro Biopharma was founded in 2003